Quantum BioPharma's MS drug candidate nears phase 2 trials
Go back to Quantum BioPharma's MS drug candidate nears phase 2 trials| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.48 -0.07 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.55 | 52 Week High | $2.00 | |||
| Open | $3.60 | 52 Week Low | $0.10 | |||
| Day High | $3.67 | P/E | N/A | |||
| Day Low | $3.37 | EPS | $0.00 | |||
| Volume | 152,094 | |||||
